/PRNewswire/ --~ Prior to the American Society of Hematology Annual Meeting ~ Kiadis Pharma B.V., a clinical stage biopharmaceutical company... ...http://in.sys-con.com/node/2886278
The Fred Hutchinson Cancer Research Center (Fred Hutch) and Memorial Sloan-Kettering Cancer Center (MSKCC), along with paediatric partner Seattle... ...http://www.pharmabiz.com/NewsDetails.aspx?aid=79091&sid=2
/PRNewswire/ --Cytos Biotechnology Ltd (SIX:CYTN) ("Cytos" or the "Company") today announced that Dr. Yamo Deniz is proposed to join Cytos' Board... ...http://in.sys-con.com/node/2884310
High-dose (HD) bolus IL-2 therapy is one of the most potent forms of immunotherapy for patients with metastatic melanoma and renal cell carcinoma.... ...http://www.medindia.net/news/how-to-predict-the-outcome-for-high-dose-il-2-therapy-in-cancer-patients-128639-1.htm
MORRIS PLAINS, N.J., Dec. 2, 2013 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the... ...http://www.bizwireexpress.com/showstoryGNW.php?storyid=12517
CANCER HEALER CENTER is a cancer...